pembrolizumab,gemcitabine,cisplatin
merck
['pembro', 'kn966']
quality of life data from kn966 (gem/cis +/- pembro) presented at #asco23 pembrolizumab did not improve quality of life - this is important when assessing the clinical value of the combination. #qualityoflife #patientsafety #patientsfirst 
Oncologist focused on #PrecisionOncology 🎯 & #PancreaticCancer 💜 •@myesmo faculty• #MissionCancer Board🇪🇺•Rolling with @OncoAlert 🚨 •Views are my own•